 |
 |
The Gary Neil Prize for Innovation in Drug DevelopmentThe Gary Neil Prize for Innovation in Drug Development was established in 2004 to honor the memory of Gary Neil, Ph.D. Dr. Neil, a former leader of worldwide Research and Development at Wyeth-Ayerst, was a pioneer in the field of drug development. Dr. Neil was instrumental in creating a highly effective drug development and strategic decision-making structure at Alza through his roles as CEO and President of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals Corporation. Dr. Neil had a significant role as a member of the boards of directors of Pharsight Corporation, Geron Corporation, Calydon and several other biotech companies.The goal of the Gary Neil Prize for Innovation in Drug Development is to stimulate the application of innovative science to clinical drug development by recognizing outstanding individuals or teams who have been leaders in this area.
EligibilityIndividuals as well as teams from the pharmaceutical or biotechnology industry are eligible for the Gary Neil Prize for Innovation in Drug Development. The only requirement is that the candidate be a leader in the application of significant, innovative science to clinical drug development.
Prize and PresentationThe Gary Neil Prize for Innovation in Drug Development will be presented at the ASCPT Annual Meeting. The recipient will receive a plaque and a $2,500 honorarium. Travel expenses, hotel expenses and meeting registration will be reimbursed by the Society.
Previous Recipients
For more information about the Gary Neil Prize for Innovation in Drug Development, please contact ASCPT at (703) 836-6981 or meetings@ascpt.org.
|
